Signifier Medical Introduces New eXciteOSA® Product Update, Expanding Access to Sleep Apnea Therapy for More Medicare and Medicaid Patients

6th March 2025

Innovative Daytime Sleep Apnea Therapy, eXciteOSA®, Now Covered by Georgia Medicaid, Reducing Healthcare Burdens and Improving Workforce Resilience

11th February 2025

Signifier Medical Technologies Secures European Union Medical Device Regulation (EU MDR) Certification for eXciteOSA®

3rd February 2025

Signifier Medical Technologies Announces Milestone Order of 10,000 eXciteOSA Devices by Leading Home Medical Equipment Provider, Spectrum Sleep Solutions Inc.

11th June 2024

Signifier Medical Technologies’ eXciteOSA Now Covered by Medicaid in South Carolina: Reaching a Wider Patient Population with Daytime Sleep Apnea Therapy

4th April 2024

New Published Study Explores Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea

6th March 2024

CMS Sets Pricing with New HCPCS Codes for eXciteOSA Therapy, Expanding Access to Innovative Daytime Sleep Apnea Treatment

15th November 2023

Signifier Medical Technologies Announces Upcoming Publication of Randomized Controlled Trial Results Examining High-Intensity (Active) Vs. Low-Intensity (Sham) Neuromuscular Electrical Stimulation in Patients for 6 Weeks

1st November 2023

Neuromuscular Electrical Stimulation as a treatment for obstructive sleep apnea gains traction with a recently announced World Sleep 2023 Congress symposium

25th September 2023

Appointment of new Board

25th August 2023